Novozymes A/S ADR | Balance Sheet
Fiscal year is January-December. All values DKK Millions.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
1,090
2,552
859
816
648
737
Total Accounts Receivable
2,694
2,575
2,714
3,089
2,903
3,278
Inventories
1,902
2,184
2,281
2,488
2,586
2,820
Other Current Assets
144
-
294
-
-
-
Total Current Assets
5,830
7,311
6,148
6,393
6,137
6,835
Net Property, Plant & Equipment
7,135
7,498
8,162
8,641
8,926
9,698
Total Investments and Advances
59
53
230
224
88
62
Long-Term Note Receivable
162
125
-
57
35
34
Intangible Assets
2,864
2,954
2,676
2,737
2,432
2,071
Other Assets
-
-
116
-
-
59
Total Assets
16,506
19,277
18,695
19,467
19,041
19,697
ST Debt & Current Portion LT Debt
105
-
116
89
971
Accounts Payable
976
1,122
1,189
1,194
1,341
Income Tax Payable
356
389
369
437
483
Other Current Liabilities
1,162
2,430
1,626
1,842
1,782
Total Current Liabilities
2,599
3,941
3,300
3,562
4,577
Long-Term Debt
1,734
1,798
1,216
1,714
1,303
Provision for Risks & Charges
151
212
186
231
159
Deferred Taxes
500
299
256
247
34
Other Liabilities
-
411
781
553
346
Total Liabilities
5,440
7,997
7,102
7,722
7,774
Common Equity (Total)
11,054
11,269
11,580
11,732
11,254
Total Shareholders' Equity
11,054
11,269
11,580
11,732
11,254
Total Equity
11,066
11,280
11,593
11,745
11,267
Liabilities & Shareholders' Equity
16,506
19,277
18,695
19,467
19,041
Accumulated Minority Interest
12
11
13
13
13
About Novozymes A/S
View Profile
